We are monitoring the impact of COVID-19 on Latin America Clinical Trials Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1574
Share on
Share on

Latin America Clinical Trials Market Analysis – Segmented By Phase, Design, Indications, By Country (Mexico, Brazil, Chile, Peru, Argentina and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast | 2020 – 2025

Pulished: February, 2020
ID: 1574
Pages: 145

As per our report, the size of the Latin American Clinical Trials Market has been estimated at USD 1.72 Billion in 2020 and is projected to reach USD 2.55 Billion by 2025 at a CAGR of 8.20% from 2020 to 2025

Complexities and volumes of data are constantly increasing in clinical trials. As the cost of development break records and patent cliffs approach, there is an urgent need for pharmaceutical companies to raise R&D efforts. Cloud and analytics convergence is omnipresent, and systematic improvements are being made in the clinical trial phase by digital technologies. Healthcare models are witnessing tectonic shifts and seeing a large inflow of new models of clinical trials that are structured, standardized, and foster patient interest. Drug companies are pushing the boundaries of R&D initiatives to improvise their models of clinical trials that will help them cope with ever-increasing development costs. For pharmaceutical and medical device firms, speedier clinical trials are crucial as they are time and capital intensive.

MARKET DRIVERS

One of the critical factors that can be related to the growth of clinical research in Latin America is their ability to meet the requirements for subject enrolment, particularly as the need for more subjects and greater diversity of patients is increasing. In addition, retention rates are generally twice in Latin America than in Western Europe, and significantly higher than in the United States and Canada. The key drivers of the clinical trial industry in LATAM usually involve rising disease prevalence, high pharmaceutical industry R&D expenditure, and growth in new treatments such as personalized medicine that supports market growth.

Regulatory systems, however, continue to evolve, and differences between different populations of patients pose ethical problems. Last but not least, there is a need to address substantial variations in regional Spanish and cultural differences among ethnic minority communities, particularly in the preparation of patient services. Some groups of patients may have reduced readability and low economic status. Specific measures need to be taken in such situations to ensure patient rights are protected.

This report on Europe Clinical Trails Market has been segmented into the following categories:

  • By Phase – Phase I, Phase II and Phase III
  • By Design - Interventional trials, Observational trials, Expanded Access trials
  • By Indications – Autoimmune, Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose & Ophthalmology  
  • By Country – Mexico, Brazil, Chile, Peru, Argentina and Rest of Latin America

Geographically, the Clinical Trials market in the Latin America region is proceeding with a high CAGR. Emerging market destinations in Latin America are attractive because of the opportunity to collect data from patients with diverse ethnic backgrounds, as well as the availability of qualified investigators, all without the competition or cost they face in more developed nations.

In Brazil, the new clinical studies lift up safety concerns about coronavirus patients that they are taking a high dose of chloroquine drug of Malaria. Brazil’s Techtrials Partnered with TriNetX healthcare organization which have 64 million patients database over the country. It covers 90% of the Brazilian population having various diseases, and it is beneficial for the institutes to take clinical trials on various diseases by knowing the availability of participants. This is the major factor responsible for the growth of the clinical trials market in Brazil. The data of patients available gives the current idea about active corona patients to treat them wisely by focusing on the research. The going on research and development to find this vaccine will give a chance to Brazil clinical trial market to set their position worldwide. 

Major companies operating in the Latin America Clinical Trails Market profiled in this report are Chiltern, Omnicare, PPD, Parexel, Kendle, Quintles, ICON Plc, and Charles River.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Phases                          

                                5.1.1 Introduction           

                                5.1.2 Phase I      

                                5.1.3 Phase II    

                                5.1.4 Phase III   

                                5.1.5  Y-o-Y Growth Analysis, By Phases                

                                5.1.6  Market Attractiveness Analysis, By Phases              

                                5.1.7  Market Share Analysis, By Phases                

                5.2 Design                          

                                5.2.1 Introduction           

                                5.2.2 Interventional trials             

                                5.2.3 Observational trials             

                                5.2.4 Expanded Access trials       

                                5.2.5  Y-o-Y Growth Analysis, By Design 

                                5.2.6  Market Attractiveness Analysis, By Design               

                                5.2.7  Market Share Analysis, By Design

                5.3 Indications                  

                                5.3.1 Introduction           

                                5.3.2 Autoimmune         

                                5.3.3 Blood disorders     

                                5.3.4 Cancer      

                                5.3.5 Circulatory               

                                5.3.6 CNS            

                                5.3.7 Congenital               

                                5.3.8 CVS            

                                5.3.9 Dermatology          

                                5.3.10 Ear            

                                5.3.11 Gastrointestinal  

                                5.3.12 Genitourinary      

                                5.3.13 Infections              

                                5.3.14 Mental disorders

                                5.3.15 Metabolic              

                                5.3.16 Musculoskeletal 

                                5.3.17 Nose       

                                5.3.18 Ophthalmology   

                                5.3.19  Y-o-Y Growth Analysis, By Indications      

                                5.3.20  Market Attractiveness Analysis, By Indications    

                                5.3.21  Market Share Analysis, By Indications      

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Phase

                                                6.1.3.3 By Design

                                                6.1.3.4 By Indication

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Phase

                                                6.1.4.3 By Design

                                                6.1.4.4 By Indication

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Phase

                                                6.1.5.3 By Design

                                                6.1.5.4 By Indication

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Chiltern                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Omnicare                    

                8.3 PPD                

                8.4 Parexel                         

                8.5 Kendle                          

                8.6 Quintles                       

                8.7 ICON Plc                       

                8.8 Charles River                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  2. Latin America Phase I Market By Region, From 2020 - 2025 ( USD Billion )
  3. Latin America Phase II Market By Region, From 2020 - 2025 ( USD Billion )
  4. Latin America Phase III Market By Region, From 2020 - 2025 ( USD Billion )
  5. Latin America Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  6. Latin America Interventional trials Market By Region, From 2020 - 2025 ( USD Billion )
  7. Latin America Observational trials Market By Region, From 2020 - 2025 ( USD Billion )
  8. Latin America Expanded Access trials Market By Region, From 2020 - 2025 ( USD Billion )
  9. Latin America Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )
  10. Latin America Autoimmune Market By Region, From 2020 - 2025 ( USD Billion )
  11. Latin America Blood disorders Market By Region, From 2020 - 2025 ( USD Billion )
  12. Latin America Cancer Market By Region, From 2020 - 2025 ( USD Billion )
  13. Latin America Circulatory Market By Region, From 2020 - 2025 ( USD Billion )
  14. Latin America CNS Market By Region, From 2020 - 2025 ( USD Billion )
  15. Latin America Congenital Market By Region, From 2020 - 2025 ( USD Billion )
  16. Latin America CVS Market By Region, From 2020 - 2025 ( USD Billion )
  17. Latin America Dermatology Market By Region, From 2020 - 2025 ( USD Billion )
  18. Latin America Ear Market By Region, From 2020 - 2025 ( USD Billion )
  19. Latin America Gastrointestinal Market By Region, From 2020 - 2025 ( USD Billion )
  20. Latin America Genitourinary Market By Region, From 2020 - 2025 ( USD Billion )
  21. Latin America Infections Market By Region, From 2020 - 2025 ( USD Billion )
  22. Latin America Mental disorders Market By Region, From 2020 - 2025 ( USD Billion )
  23. Latin America Metabolic Market By Region, From 2020 - 2025 ( USD Billion )
  24. Latin America Musculoskeletal Market By Region, From 2020 - 2025 ( USD Billion )
  25. Latin America Nose Market By Region, From 2020 - 2025 ( USD Billion )
  26. Latin America Ophthalmology Market By Region, From 2020 - 2025 ( USD Billion )
  27. Brazil Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  28. Brazil Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  29. Brazil Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )
  30. Argentina Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  31. Argentina Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  32. Argentina Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )
  33. Mexico Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  34. Mexico Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  35. Mexico Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )
  36. Rest of Latin America Clinical Trial Market By Phase, From 2020 - 2025 ( USD Billion )
  37. Rest of Latin America Clinical Trial Market By Design, From 2020 - 2025 ( USD Billion )
  38. Rest of Latin America Clinical Trial Market By Indications, From 2020 - 2025 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample